Nav: Home

Low-protein diet during pregnancy increases prostate cancer risk in offspring

August 06, 2018

The offspring of females fed a low-protein diet during pregnancy and lactation are significantly more likely to develop prostate cancer as they age.

This is the main finding of a study performed with rats at São Paulo State University's Bioscience Institute (IBB-UNESP) in Botucatu, Brazil. The results of the study, which was supported by the São Paulo Research Foundation (FAPESP), have been published in The Journals of Gerontology: Series A.

"Our previous research showed that intrauterine exposure to a low-protein diet impairs prostate development. Our latest published study proves that this effect observed postnatally increases the incidence of prostate disease when the individuals concerned are older," said Luis Antonio Justulin Junior, a professor at IBB-UNESP and principal investigator for the study.

The model used in Justulin's laboratory consists of feeding pregnant females a diet with only 6% protein. Laboratory rats are normally fed a diet that contains between 17% and 23% protein.

"Data in the literature show 12% to be the minimum protein content needed for rats to carry a pregnancy to term without problems," Justulin said.

The pregnant rats included in the study were divided into three groups. The control group was fed the standard diet with at least 17% protein during pregnancy and a 21-day lactation period. After weaning, the offspring were also fed the standard diet. No cases of prostate cancer were found in these offspring 540 days after birth, when rats were considered old.

The second group of females were fed the 6% protein diet only during pregnancy. After giving birth, they were fed the standard diet, as were their weaned offspring. In the assessment performed 540 days after birth, 33% of their male offspring had developed prostate cancer. The third group was fed the low-protein diet throughout pregnancy and lactation, and 50% of their offspring developed prostate cancer.

"We performed a histopathological analysis on these animals' prostates, and in all three groups, we found preneoplastic alterations capable of interfering with glandular function, such as hyperplasia, epithelial atrophy and intraepithelial neoplasia; the latter has the potential to become carcinoma, according to data in the scientific literature," said the FAPESP-supported researcher. "However, cancer was found only in the animals exposed to the low-protein diet in their intrauterine life."

Hormone imbalance

The previous study, published in 2017 in General and Comparative Endocrinology, described some of the impairments caused in offspring by a maternal low-protein diet.

The analysis performed on the tenth and twentieth days after birth showed that compared with prostates in the offspring of females fed the normal diet, those in the offspring of females fed the low-protein diet were smaller and had fewer differentiated epithelial cells, which is considered a sign of retarded development. The prostate also displayed functional impairment, secreting and storing less prostate fluid.

It is worth recalling that the function of the prostate is to produce the fluid that protects and nourishes sperm in semen, making it more dilute.

"Generally speaking, these animals had low birth weight, less developed organs, and altered hormone levels," Justulin said. "However, around the twenty-first day after birth, we began to see accelerated growth to try to make up for the deficit."

In a recently published study, researchers collected blood from male pups on postnatal days 21 and 540. They found an imbalance between female and male hormone levels between the offspring of mothers fed a low-protein diet and the offspring of the control group.

While control males had 15 picograms (pg) of estrogen on PND 21, males born to rats fed the low-protein diet during pregnancy and lactation had 20 pg. On PND 540, the difference was even greater: 14 pg versus 35 pg, respectively.

Moreover, on PND 540, increased female hormone levels were associated with a decrease in the level of testosterone, the main male hormone. Control mice had 5 nanograms (ng), while those from the low-protein diet group had only 0.8 ng.

According to Justulin, no decrease in testosterone was observed in the low-protein diet group on PND 21 because this is the stage at which rat pups are growing the fastest.

"Our prior research showed that pups exposed to an intrauterine low-protein diet were born small but that as young adults they no longer displayed differences compared with controls in terms of size, prostate volume or hormone levels," said the FAPESP research project coordinator. "In our new study, the differences reappeared as they aged. It's as if aging were a second insult to the organism, considering that the first was the low-protein diet in the initial stage of development."

Researchers are now testing the hypothesis that exposure to altered hormone levels in old age favors carcinogenesis (tumor formation).

"We observed this in the prostate, but other studies show low birth weight induced by maternal undernourishment is correlated with altered insulin levels and increased incidence of metabolic syndrome and heart disease," Justulin said.

The research group at IBB-UNESP is currently investigating sex hormone synthesis pathways with the aim of understanding how a low-protein diet affects the estrogen-testosterone balance. They also want to demonstrate the mechanism through which hormone imbalance can favor the development of prostate cancer.

Preliminary results of this research point to dysregulated messenger RNAs and microRNAs in the restricted-diet animals on postnatal day 21.

"We found several messenger RNAs and microRNAs that were dysregulated in both pups at 21 days and 540-day-old animals with cancer," Justulin said. "What's interesting is that some of these molecules are also altered in human patients with prostate tumors, according to our analysis of public genome databases with the aid of bioinformatics tools."
About São Paulo Research Foundation (FAPESP)

The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. For more information:

Fundação de Amparo à Pesquisa do Estado de São Paulo

Related Prostate Cancer Articles:

The Lancet: Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer
Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.
Common genetic defect in prostate cancer inspires path to new anti-cancer drugs
Researchers found that, in prostate cancer, a mutation leading to the loss of one allele of a tumor suppressor gene known as PPP2R2A is enough to worsen a tumor caused by other mutations.
First prostate cancer therapy to target genes delays cancer progression
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, reports a large phase 3 trial.
Men taking medications for enlarged prostate face delays in prostate cancer diagnosis
University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.
CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer
The study has potential implications for families with members suffering from these types of tumours who are at an increased risk of developing cancer.
Distinguishing fatal prostate cancer from 'manageable' cancer now possible
Scientists at the University of York have found a way of distinguishing between fatal prostate cancer and manageable cancer, which could reduce unnecessary surgeries and radiotherapy.
Researchers find prostate cancer drug byproduct can fuel cancer cells
A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic.
ASCO and Cancer Care Ontario update guideline on radiation therapy for prostate cancer
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer.
Patient prostate tissue used to create unique model of prostate cancer biology
For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track how the tumor progresses.
Moffitt Cancer Center awarded $3.2 million grant to study bone metastasis in prostate cancer
Moffitt researchers David Basanta, Ph.D., and Conor Lynch, Ph.D., have been awarded a U01 grant to investigate prostate cancer metastasis.
More Prostate Cancer News and Prostate Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

One of the most consistent questions we get at the show is from parents who want to know which episodes are kid-friendly and which aren't. So today, we're releasing a separate feed, Radiolab for Kids. To kick it off, we're rerunning an all-time favorite episode: Space. In the 60's, space exploration was an American obsession. This hour, we chart the path from romance to increasing cynicism. We begin with Ann Druyan, widow of Carl Sagan, with a story about the Voyager expedition, true love, and a golden record that travels through space. And astrophysicist Neil de Grasse Tyson explains the Coepernican Principle, and just how insignificant we are. Support Radiolab today at